A 3 S T RA C T Carnitine is synthesized from lysine and metlhionine. In the rat, inade(quiate intake of either of these essential amino acids cauises carnitinie depletioIn 14 of' 36 hospitalized cirrhotics hald subnormal valtues for seruim carnitine. The creatinine/height index, midarm munscle circumference, and triceps skin-fold thickness indicated protein-calorie starvation in the 14 hypocarnitinemic liver patients. In six of the hypocarnitinemic cirrhotics (average seruim level 50% of normal), spontaneouis dietary intakes of' carnitine, lysine, and methionine were measuired and foulnd to be only 5-15% as great as in six normocarnitinemiic, healthy controls. When these six cirrhotic anuI six normnal stil)jects were given the same lysine-rich, methioninle-ricl, and carnitine-free nultritionaitl intake, the normaiitls mnain tained n oi-'matl serumiii camr iti ne levels and exeretedl 100 tLmol/day, wvhereas the cirrlhoties' sertum level fell to 25% of noimatl, and(l uirinary excretion dec ined to 15 Lmol/day. Seven lhypocarniitiniemic cirrhotics dlie(l. P'ostmlortemn concentratioons of' carnitine in liver, musele, heart, kidney, and brain averagedl only one-fouirtlh to onethir(d those in corresponding tisstues of eight normally noutrished nonhepatic patients who died after an actute illness of a 1-3-day duiration.
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These data show that carn-itine depletion is common in pattients hospitalized for advanced cirrhosis, and that it resuilts from three factors: stubstandard intake of dietary carnitine; substandard intake of lysine and methionine, the prectursors ftor endlogenouis carnitine synthesis; acnd loss of' cappacity to syntlhesize carnitine from lysine and methiioniine.
INTRODUCTION
Carnitine is a trimethylated y-amin(o acid which is present in all mammalian tisstues. It plays an essential role in fatty acid oxidation becauise fatty acids muist be esterified with carnitine in order to be transported from the cytoplasm into mitochondria, where the oxidation occuirs (1) . The body's stupply of' carnitine is derived in part by ingestion of' preformed dietary carnitine, and in part b)y endogenous synthesis from the essential amino acids lysine and methionine (2) (3) (4) (5) .
Step 3 in the synthetic pathway ( Fig. 1) (10, 11) .
Protein deficiency is currently prevalent within the hospital population. Recent surveys have revealed evidence of protein-calorie undernutrition in about one-third of patients on the medical and surgical services in two hospitals (12, 13) . The rapid development of carnitine deficiency in rats fed a diet deficient in essential amino acids suggested to us that unrecognized camitine deficiency could be endemic in patients with nosocomial malnutrition. The present study was designed to test this idea.
METHODS
Experimental design. The study proceeded in three phases.
Phase A. Camitine level in serum was measured in 16 normal subjects and 247 hospital patients in 16 disease categories. All sera were drawn at 7-9 a.m. while the subjects were fasting. 14 cirrhotic patients with hypocarnitinemia were identified.
Phase B. To investigate the cause of the subnormal plasma camitine level in the 14 cirrhotics, 6 were transferred to the metabolic research unit for an 18-day study. During days 1-6, their spontaneous dietary intake of carnitine, lysine, and methionine was measured, together with the simultaneous serum and urine levels of carnitine. They then received for 6 days carnitine-free oral and parenteral nutrition providing two to three times the recommended daily allowance (RDA)' of lysine and methionine, while serum concentration and urinary excretion of carnitine continued to be monitored. During days 13 (14) , midarm muscle circumference (MAMC) and triceps skin-fold thickness (TSF) (15, 16) , creatinine/height ratio (17) , and serim albumin level and hematocrit.
Carnitine analysis. Free and total (i.e., free pltus esterified) L-camitine were determined enzymatically by the coupled spectrophotometric assay of Marquis and Fritz (18) in plasma (19) , urine (20) , tissue (21) , and food (21) . Preliminary experiments showed that carnitine contents of rat tissues did not change detectably while the carcass was stored for 24 constructed from 25 foods of known carnitine (Table V) , lysine (22) , and methionine (22) contents, and their intake of each food was measured. During the next 6 days, the normal subjects were fed an oral diet containing <10
,umol carnitine/day, 2,200-2,400 calories, and 80-90 g protein or amino acids containing 3,200-3,400 mg lysine and 2,000-2,200 mg methionine. The cirrhotic patients, because of anorexia, received 300-800 ml Freamine II (McGaw Labs., Glendale, Calif.) and 300-1,000 ml 10% glucose intravenously each day to achieve the same intakes (+15%) of carnitine, calories, and amino acids as the healthy controls. Dturing days 13-18 of phase B, the intakes were the same as during days 6-12 except that an oral stupplement of 500 ,tmol D,L-carnitine (Sigma Chemical Co., St. Lotiis, Mo.) was added. For patients stuldied under phase C, no information on dietary intake dturing the months hefore death was available.
RESULTS
Phiase A. Table I slhows the results of surveying serum carnitine level in 16 normals, 211 nonhepatic patients, and 36 cirrhotics. In the normal group, average±+SE for serum-total carnitine was 79+3 ,M; thuts, the normal range, defined as average +2 SD, was 55-103 uM. For serum-free carnitine, normal average was 49 AM and normal range was ,tM. In 16 nonhepatic disease groups, average valtues for sertum-total and serum-free carnitine did not differ significantly (P > 0.05) from normal (Table I ). In the cirrhotic group, contrastingly, average ranges for both total and free concentrations were significantly depressed (P < 0.05). In 14 of the 36 cirrhotics, the seruim level was below the normal ranige (total <55 ,aXI, free <25 LM).
Ntutritional evaluation of' the 14 hylpocarnitinemiic eirrlhoties, as compared to the 16 normals (Table V'I) , showed severely redtuced creatinine/lheiglht index, MANIC, and TSF, consistenit with advanced proteincalorie starvation (14, 15, 17) . The hypocarniitiniemic cirrlhotics also hlad severe hepatocelltular disease, as revealed by the plasmua levels of albunminl, bilirtubin, and prothrombin (Table VI (Table VI) .
Phase B. Six of the cirrhotic patients witlh stbnormal serum carnitine were transferred to the metabolic research unit for phase B. The clinical data (Table II) showed all six patients to have severe (Childs Class C [23] ) liver disease of >a 6-yr dturation.
Body weiglht was not uisefuil for evaluatioin of ntutrition because of ascites, but MAMC, TSF, and creatinine/height ratio were uiniformly <70% of standard, albtumin was <2.5 g/100 g, and hematocrit was <30%. Dturing days 1-6 of phase B, all six hypocarnitinemic cirrhotics were fotund to be markedly anoretic. Their spontaneouis ad lib. intake of calories, carbohydrate, Carnitine Deficienicy 717 Fig. 2 ).
The six cirrhotic and six normal subjects now received, during davs 6-12, oral and parenteral ntutrition fu-rnishing each day <10 ,umol carnitine and 80-86 g protein containing two to four times the RDA of lysine and methionine. In the control group, serumtotal and serum-free carnitine remained within the normal ranges; urinary excretion declined in 2 days to 100/55 (total/free) ,umol/day and remained at this level for the next 4 days. In the cirrhotics, serum concentration declined from the 6th-day value of 28/18 (total/free) to 20/10 ,uM on day 12; the reduction however was not significant (P > 0.05). Urine total carnitine remained in the range [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] ,umol/day during days [6] [7] [8] [9] [10] [11] [12] Table II1. body weight 105-140% of ideal, and history negative for recent anorexia or weight loss) wlho died after an acute illness of a 1-3-day duration. In the cirrhotic patients' pectoral muscle, heart, liver, kidney, and brain, concentrations of both total and free carnitine wTere only 16-40% as great as in the nonhepatic, normiially nourished cases (P < 0.05).
DISCUSSION
In seeking explanations for the subnormnal serum, urine, and tissue levels of carnitine in the undernourished cirrhotics eating hospital diets ad lib, we must consider the dual source of carnitine in the body: (a) intake of preformed exogenous carnitine and (b) endogenous synthesis, from exogenous lysine and methionine contained in dietary protein. In the normal rat, body carnitine turns over approximately every 15 days (24) and over 90% is excreted unmetabolized in the urine (25) . As a first approximation, we assume therefore that in normal man, urinary carnitine/day is equal to intake of dietary carnitine/day + carnitine synthesized endogenously/day.
The present study shows intake of exogenous carnitine by normal subjects eating a diet selected from 25 common foodstuiffs (Table V) is 380-450,tmol, and a similar amount is excreted in the urine. Therefore, endogenous synthesis in normal individuals eating about 400 ,tmol exogenous carnitine/day is probably close to zero. When exogenous intake is reduced below 10 lmol/day, and the precursors continue to be supplied, urinary excretion by healthy subjects stabilizes at 100 gmol/day, which probably approximates the rate of endogenous synthesis when the diet lacks carnitine. There is no nutritional requirement for exogenous carnitine in the rat or in man; thus, in normal subjects eating a carnitine-free diet, the rate of endogenous synthesis (about 100
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/,tmol/day) is adequiate to maintain normal fatty acid metabolism witlhin cells. This concltusion is supported by the fact that serumn carnitine of normnal suibjects eating a carnitine-free, lysine-and methionine-riecb diet remained normal wvhile turinary excretion stal)ilized at 100 urmol/day (days 6-12, Fig. 2 ). The suibnormial serulm, turinie, aind tisstue carnitine levels in the aclahectic cirrhotic subljects resuilted from at least three fhictors. (a) Because of anorexia, their average spontaneouis daily intake of ex nogenos carnitine was only 29 ,smol (days 1-6 of plhase B, Table LII), (b) Anorexia also cauised inadequate intake of dietary protein, including the carnitine precuirsors lysine and methionine (days 1-6, Table III ). In the normal rat, these conditions, a carnitine-free diet deficient in either lysine or methionine, vill rapidly cause depletion of carnitine in muscle, liver, kidney, and brain (10) (11) (12) . (c) Btut in cirrhotic man a third factor operates as well: endogenous biosynthesis of carnitine from lysine and methionine is defective. This abnormality is shown by the comparison of normal and cirrhotic stubjects receiving the carnitine-free, lysineand methionine-rich ntutritional regimen (days 6-12 of phase B, Fig. 2 Fig. 2) suggests that methionine and choline deficiencies were not the primary cause of the carnitine depletion, and that a substantial loss of endogenous synthetic capacity had indeed occurred. The most likely reason for a loss of capacity to synthesize carnitine is inability to convert y-butyrobetaine to carnitine (Fig. 1) , a reaction which occurs only in the liver. However, impaired synthesis of trimethyllysine or butyrobetaine in extrahepatic tissues is also possible because of reduced muscle mass or diversion of lysine and methionine to other pathways in these patients with severe protein-calorie starvation. These alternative mechanisms can be tested in future studies by observing the effect of dietary supplements oftrimethyllysine and of butyrobetaine on serum and urinary carnitine in hypocarnitinemic cirrhotic patients.
A contributory cauise to the hypocarnitinuria in the hypocarnitinemic cirrhotics of phase B was their subnormal rate of glomerular filtration, as revealed by low creatinine clearance (Table II) .
It is notable that in the normal subjects, when carnitine was removed from the diet (day 1-6 of phase B, Fig. 2 ), carnitine excretion dropped 75% without any change in fasting serum levels. What was the signal to the kidney to retain carnitine on the low carnitine, lysine-and methionine-rich diet? One possibility is that postprandial hypercarnitinemia follows ingestion of carnitine-containing foods, and that the major excretion of carnitine occurs during the periods of elevated serum carnitine during the hours after such meals. Under these circumstances, removal of carnitine from the diet would reduce 24 h urinary carnitine without altering fasting sertum carnitine. It is also possible that the renal tubular reabsorption of carnitine is influenced by the lysine and methionine intake.
Although nutrition was not evaluated in the nonhepatic patients in Table I (Table IV) . For several reasons, however, the data in Table IV (6) (7) (8) (9) . Since all three of these abnormalities occtur frequently in patients with advanced cirrhosis, it is possible that the presently demonstrated carnitine deficiency could play a role in the pathogenesis of these common manifestations of acquired liver disease. If so, correction of the carnitine deficiency by oral stupplements of the compound may prove beneficial.
